Europe Learns The Truth(s) About ACTA 07/04/2010 by Monika Ermert for Intellectual Property Watch 4 Comments The truth about the Anti-Counterfeiting Trade Agreement (ACTA) is different depending on which side you are on.
United States Sees Spate Of Intellectual Property Policy Activity 07/04/2010 by Kaitlin Mara for Intellectual Property Watch 2 Comments In the aftermath of the recent protracted fights over healthcare, the United States has seen a wave of intellectual property-related policy activity
Special Report: The Significance Of Europe’s Ruling On Google Ads And Trademarks 07/04/2010 by Steven Seidenberg for Intellectual Property Watch Leave a Comment The European Court of Justice’s recent ruling in Google v. Louis Vuitton Malletier SA has been hailed a major legal victory for Google and other search providers. That, however, is only part of the story.
Risk Of Wrongful Medicines Seizures Seen In EU-Central America Trade Deal 06/04/2010 by David Cronin for Intellectual Property Watch 1 Comment A new accord designed to bolster political and economic ties between the European Union and Central America could result in greater seizures of medicines whenever pharmaceutical companies allege that their patents have been infringed, public health advocates have warned.
在WHO就假冒伪劣药品问题吹风会上观点激烈交锋 03/04/2010 by Kaitlin Mara for Intellectual Property Watch Leave a Comment 世界卫生组织就处理假冒伪劣（conterfeit）药品问题继续开展工作，但是上周晚些时候召开的一个会议暴露出一些方面对该组织的工作方式表示担心。
Débat houleux lors d’une réunion d’information organisée par l’OMS sur les médicaments contrefaits 01/04/2010 by Kaitlin Mara for Intellectual Property Watch 2 Comments Alors que l’Organisation mondiale de la Santé (OMS) continue de travailler sur la question des médicaments contrefaits, une réunion organisée en fin de semaine dernière a révélé des inquiétudes quant à la manière dont ce travail est mené.
Mordaz intercambio de puntos de vista en la reunión informativa de la OMS sobre medicamentos falsificados 01/04/2010 by Kaitlin Mara for Intellectual Property Watch Leave a Comment La Organización Mundial de la Salud (OMS) continúa trabajando en el tema de los medicamentos falsificados, pero la semana pasada una reunión reveló preocupaciones progresivas sobre la forma de conducir la labor.
Pointed Exchange Of Views At WHO Briefing On Counterfeit Drugs 31/03/2010 by Kaitlin Mara for Intellectual Property Watch 1 Comment Work to address counterfeit medicines continues at the World Health Organization, but a meeting late last week revealed ongoing concerns about the way it is being conducted.
Leaked ACTA Text Shows Possible Contradictions With National Laws 29/03/2010 by Monika Ermert for Intellectual Property Watch 4 Comments “No changes in domestic” law promised the partners currently negotiating the Anti-Counterfeiting Trade Agreement. A leaked 56-page recent consolidated version of the much-discussed agreement shows that this might not be completely true. The draft version with a lot of bracketed text in it shows that some countries are more open about the potential need to change their domestic laws than others.
EU To Request Publication Of ACTA Documents To Stop “Rumours”; Civil Society Meeting Planned 22/03/2010 by Monika Ermert for Intellectual Property Watch Leave a Comment Europe will request the publication of the current drafts for the Anti-Counterfeiting Trade Agreement (ACTA) at the next ACTA negotiating meeting in New Zealand in April, EU trade official Luc Devigne said today. Speaking at the third EU stakeholder meeting on the hotly debated ACTA today in Brussels, Devigne also said there is also a meeting with civil society planned to take place alongside the New Zealand round.